Transmucosal hormone delivery system
US9254294B2 · kind B2 · utility
2Cited by
28References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 14, 2014 |
| Grant date | Feb 9, 2016 |
| Priority date | — |
| Expiry date | Mar 14, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2018
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a pharmaceutical composition for sublingual or buccal administration of actives with low to poor aqueous solubility, e.g. the hormone estradiol, which contains a solution of the active in a pharmaceutically acceptable solvent adsorbed or absorbed onto particles of a pharmaceutically acceptable carrier and methods of preparing and using the pharmaceutical composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.